Cargando…
Omicron infection enhances Delta antibody immunity in vaccinated persons
The extent to which Omicron infection(1–9), with or without previous vaccination, elicits protection against the previously dominant Delta (B.1.617.2) variant is unclear. Here we measured the neutralization capacity against variants of severe acute respiratory syndrome coronavirus 2 in 39 individual...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279144/ https://www.ncbi.nlm.nih.gov/pubmed/35523247 http://dx.doi.org/10.1038/s41586-022-04830-x |
_version_ | 1784746330781908992 |
---|---|
author | Khan, Khadija Karim, Farina Cele, Sandile Reedoy, Kajal San, James Emmanuel Lustig, Gila Tegally, Houriiyah Rosenberg, Yuval Bernstein, Mallory Jule, Zesuliwe Ganga, Yashica Ngcobo, Nokuthula Mazibuko, Matilda Mthabela, Ntombifuthi Mhlane, Zoey Mbatha, Nikiwe Miya, Yoliswa Giandhari, Jennifer Ramphal, Yajna Naidoo, Taryn Sivro, Aida Samsunder, Natasha Kharsany, Ayesha B. M. Amoako, Daniel Bhiman, Jinal N. Manickchund, Nithendra Abdool Karim, Quarraisha Magula, Nombulelo Abdool Karim, Salim S. Gray, Glenda Hanekom, Willem von Gottberg, Anne Milo, Ron Gosnell, Bernadett I. Lessells, Richard J. Moore, Penny L. de Oliveira, Tulio Moosa, Mahomed-Yunus S. Sigal, Alex |
author_facet | Khan, Khadija Karim, Farina Cele, Sandile Reedoy, Kajal San, James Emmanuel Lustig, Gila Tegally, Houriiyah Rosenberg, Yuval Bernstein, Mallory Jule, Zesuliwe Ganga, Yashica Ngcobo, Nokuthula Mazibuko, Matilda Mthabela, Ntombifuthi Mhlane, Zoey Mbatha, Nikiwe Miya, Yoliswa Giandhari, Jennifer Ramphal, Yajna Naidoo, Taryn Sivro, Aida Samsunder, Natasha Kharsany, Ayesha B. M. Amoako, Daniel Bhiman, Jinal N. Manickchund, Nithendra Abdool Karim, Quarraisha Magula, Nombulelo Abdool Karim, Salim S. Gray, Glenda Hanekom, Willem von Gottberg, Anne Milo, Ron Gosnell, Bernadett I. Lessells, Richard J. Moore, Penny L. de Oliveira, Tulio Moosa, Mahomed-Yunus S. Sigal, Alex |
author_sort | Khan, Khadija |
collection | PubMed |
description | The extent to which Omicron infection(1–9), with or without previous vaccination, elicits protection against the previously dominant Delta (B.1.617.2) variant is unclear. Here we measured the neutralization capacity against variants of severe acute respiratory syndrome coronavirus 2 in 39 individuals in South Africa infected with the Omicron sublineage BA.1 starting at a median of 6 (interquartile range 3–9) days post symptom onset and continuing until last follow-up sample available, a median of 23 (interquartile range 19–27) days post symptoms to allow BA.1-elicited neutralizing immunity time to develop. Fifteen participants were vaccinated with Pfizer's BNT162b2 or Johnson & Johnson's Ad26.CoV2.S and had BA.1 breakthrough infections, and 24 were unvaccinated. BA.1 neutralization increased from a geometric mean 50% focus reduction neutralization test titre of 42 at enrolment to 575 at the last follow-up time point (13.6-fold) in vaccinated participants and from 46 to 272 (6.0-fold) in unvaccinated participants. Delta virus neutralization also increased, from 192 to 1,091 (5.7-fold) in vaccinated participants and from 28 to 91 (3.0-fold) in unvaccinated participants. At the last time point, unvaccinated individuals infected with BA.1 had low absolute levels of neutralization for the non-BA.1 viruses and 2.2-fold lower BA.1 neutralization, 12.0-fold lower Delta neutralization, 9.6-fold lower Beta variant neutralization, 17.9-fold lower ancestral virus neutralization and 4.8-fold lower Omicron sublineage BA.2 neutralization relative to vaccinated individuals infected with BA.1. These results indicate that hybrid immunity formed by vaccination and Omicron BA.1 infection should be protective against Delta and other variants. By contrast, infection with Omicron BA.1 alone offers limited cross-protection despite moderate enhancement. |
format | Online Article Text |
id | pubmed-9279144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-92791442022-07-15 Omicron infection enhances Delta antibody immunity in vaccinated persons Khan, Khadija Karim, Farina Cele, Sandile Reedoy, Kajal San, James Emmanuel Lustig, Gila Tegally, Houriiyah Rosenberg, Yuval Bernstein, Mallory Jule, Zesuliwe Ganga, Yashica Ngcobo, Nokuthula Mazibuko, Matilda Mthabela, Ntombifuthi Mhlane, Zoey Mbatha, Nikiwe Miya, Yoliswa Giandhari, Jennifer Ramphal, Yajna Naidoo, Taryn Sivro, Aida Samsunder, Natasha Kharsany, Ayesha B. M. Amoako, Daniel Bhiman, Jinal N. Manickchund, Nithendra Abdool Karim, Quarraisha Magula, Nombulelo Abdool Karim, Salim S. Gray, Glenda Hanekom, Willem von Gottberg, Anne Milo, Ron Gosnell, Bernadett I. Lessells, Richard J. Moore, Penny L. de Oliveira, Tulio Moosa, Mahomed-Yunus S. Sigal, Alex Nature Article The extent to which Omicron infection(1–9), with or without previous vaccination, elicits protection against the previously dominant Delta (B.1.617.2) variant is unclear. Here we measured the neutralization capacity against variants of severe acute respiratory syndrome coronavirus 2 in 39 individuals in South Africa infected with the Omicron sublineage BA.1 starting at a median of 6 (interquartile range 3–9) days post symptom onset and continuing until last follow-up sample available, a median of 23 (interquartile range 19–27) days post symptoms to allow BA.1-elicited neutralizing immunity time to develop. Fifteen participants were vaccinated with Pfizer's BNT162b2 or Johnson & Johnson's Ad26.CoV2.S and had BA.1 breakthrough infections, and 24 were unvaccinated. BA.1 neutralization increased from a geometric mean 50% focus reduction neutralization test titre of 42 at enrolment to 575 at the last follow-up time point (13.6-fold) in vaccinated participants and from 46 to 272 (6.0-fold) in unvaccinated participants. Delta virus neutralization also increased, from 192 to 1,091 (5.7-fold) in vaccinated participants and from 28 to 91 (3.0-fold) in unvaccinated participants. At the last time point, unvaccinated individuals infected with BA.1 had low absolute levels of neutralization for the non-BA.1 viruses and 2.2-fold lower BA.1 neutralization, 12.0-fold lower Delta neutralization, 9.6-fold lower Beta variant neutralization, 17.9-fold lower ancestral virus neutralization and 4.8-fold lower Omicron sublineage BA.2 neutralization relative to vaccinated individuals infected with BA.1. These results indicate that hybrid immunity formed by vaccination and Omicron BA.1 infection should be protective against Delta and other variants. By contrast, infection with Omicron BA.1 alone offers limited cross-protection despite moderate enhancement. Nature Publishing Group UK 2022-05-06 2022 /pmc/articles/PMC9279144/ /pubmed/35523247 http://dx.doi.org/10.1038/s41586-022-04830-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Khan, Khadija Karim, Farina Cele, Sandile Reedoy, Kajal San, James Emmanuel Lustig, Gila Tegally, Houriiyah Rosenberg, Yuval Bernstein, Mallory Jule, Zesuliwe Ganga, Yashica Ngcobo, Nokuthula Mazibuko, Matilda Mthabela, Ntombifuthi Mhlane, Zoey Mbatha, Nikiwe Miya, Yoliswa Giandhari, Jennifer Ramphal, Yajna Naidoo, Taryn Sivro, Aida Samsunder, Natasha Kharsany, Ayesha B. M. Amoako, Daniel Bhiman, Jinal N. Manickchund, Nithendra Abdool Karim, Quarraisha Magula, Nombulelo Abdool Karim, Salim S. Gray, Glenda Hanekom, Willem von Gottberg, Anne Milo, Ron Gosnell, Bernadett I. Lessells, Richard J. Moore, Penny L. de Oliveira, Tulio Moosa, Mahomed-Yunus S. Sigal, Alex Omicron infection enhances Delta antibody immunity in vaccinated persons |
title | Omicron infection enhances Delta antibody immunity in vaccinated persons |
title_full | Omicron infection enhances Delta antibody immunity in vaccinated persons |
title_fullStr | Omicron infection enhances Delta antibody immunity in vaccinated persons |
title_full_unstemmed | Omicron infection enhances Delta antibody immunity in vaccinated persons |
title_short | Omicron infection enhances Delta antibody immunity in vaccinated persons |
title_sort | omicron infection enhances delta antibody immunity in vaccinated persons |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279144/ https://www.ncbi.nlm.nih.gov/pubmed/35523247 http://dx.doi.org/10.1038/s41586-022-04830-x |
work_keys_str_mv | AT khankhadija omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT karimfarina omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT celesandile omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT reedoykajal omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT sanjamesemmanuel omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT lustiggila omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT tegallyhouriiyah omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT rosenbergyuval omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT bernsteinmallory omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT julezesuliwe omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT gangayashica omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT ngcobonokuthula omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT mazibukomatilda omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT mthabelantombifuthi omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT mhlanezoey omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT mbathanikiwe omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT miyayoliswa omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT giandharijennifer omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT ramphalyajna omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT naidootaryn omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT sivroaida omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT samsundernatasha omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT kharsanyayeshabm omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT amoakodaniel omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT bhimanjinaln omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT manickchundnithendra omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT abdoolkarimquarraisha omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT magulanombulelo omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT abdoolkarimsalims omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT grayglenda omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT hanekomwillem omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT vongottberganne omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT miloron omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT gosnellbernadetti omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT lessellsrichardj omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT moorepennyl omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT deoliveiratulio omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT moosamahomedyunuss omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons AT sigalalex omicroninfectionenhancesdeltaantibodyimmunityinvaccinatedpersons |